SignatureFD’s Caribou Biosciences CRBU Stock Holding History

SignatureFD’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-750	Closed	-$1.19K	–	3342
2024 Q4	$1.19K	Hold	750	–	–	﹤0.01%	2994
2024 Q3	$1.47K	Hold	750	–	–	﹤0.01%	2913
2024 Q2	$1.23K	Sell	750 -62	-8%	-$198	﹤0.01%	2865
2024 Q1	$4.17K	Buy	812 +750	+1,210%	+$4.63K	﹤0.01%	2596
2023 Q4	$355	Buy	+62	New	+$306	﹤0.01%	3004
2023 Q1	–	Sell	-172	Closed	-$1.08K	–	3298
2022 Q4	$1.08K	Buy	+172	New	+$1.53K	﹤0.01%	2963

Other funds holding CRBU

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SignatureFD's CRBU Position: Q1 2025 in Review

SignatureFD sold out of Caribou Biosciences (CRBU) in Q1 2025, closing a stake of 750 shares — an estimated $1.19K sold.

SignatureFD first reported a position in CRBU in Q4 2022 and held it in 6 quarters. The position peaked at $4.17K in Q1 2024. 131 funds tracked by Wall St. Rank hold CRBU as of Q1 2025.

SignatureFD reported no remaining Caribou Biosciences position as of Q1 2025 after selling out during the quarter.
SignatureFD sold 750 Caribou Biosciences shares in Q1 2025, an estimated $1.19K.
SignatureFD first reported a position in Caribou Biosciences in Q4 2022 and held it in 6 quarters.
SignatureFD's Caribou Biosciences position peaked at $4.17K in Q1 2024.
131 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2025.

Based on SignatureFD's 13F filing for Q1 2025, filed 2 May 2025.